US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Anti-Pandemic Concept

1,824.99

-37.6785-2.02%

Number of Gainers:4

Number of Losers:15

Number of Flat:- -

PE:- -

High:1,862.69

Open:1,861.76

Low:1,823.97

Close:1,862.66

Volume:87.22M

Turnover:8.25B

Market Cap:1.48T

Float Cap:1.45T

Loading ...

Pfizer's Tilrekimig Phase 3 Program Seen as Potential Upside Driver, UBS Says

MT Newswires Live

BioNTech to Proceed with Site Closures After Failing to Find Buyer

US Drugmakers Turn to China for Licensing Deals

NanoViricides Starts Phase II DRC Trial of Oral NV-387 Gummies in Bundibugyo Ebola Patients

Humacyte Adds Scott Coward to Board, Names Him to Audit Committee

Xilio Therapeutics Names Yariv Houvras Chief Medical Officer

Pfizer to Present Phase 3 SigVie-002 Survival Data for Sigvotatug Vedotin in Previously Treated NSCLC at ESMO 2026

Berenberg Bank Sticks to Its Hold Rating for Bilfinger (0NRG)

Abbott Study Links CGM Use in Type 2 Diabetes Patients on Basal Insulin to 45% Lower 12-Month Mortality Risk

Pfizer (PFE) Bets Big on RSV and Cancer Care

NYSE Most Active Issues

NASDAQ New 52-Week Highs and Lows

Pfizer Targets Cancer-Related Weight Loss With New Ponsegromab Study

Pfizer’s RSV Revaccination Trial Targets Durable Booster Revenue in High‑Risk Adults

AstraZeneca Advances Friday, Outperforms Market

Innovation is Driving a New Bull Market in Biotech. 16 Ways to Play It, from Our Roundtable Experts.

European Equities Traded in the US as American Depositary Receipts Edge Higher in Friday Trading; Down for Week

MT Newswires Live

Ocugen Shares Rise on Provisional Approval for Retinitis Pigmentosa Treatment in Bahamas

Johnson & Johnson says Tremfya met endpoints in Phase 4 STAR study

Johnson & Johnson Announces Tremfya® (Guselkumab) is the First and Only Il-23 Inhibitor to Show Significant Improvement in Spinal Pain and Stiffness in Landmark Axial Psoriatic Arthritis (Psa) Study

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg1.tigeractivity.com/stock/BK4568/news?page=6"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4568","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4568\",,,,,undefined,":{"symbol":"BK4568","market":"US","secType":"PLATE","nameCN":"Anti-Pandemic Concept","latestPrice":1824.9855,"timestamp":1790884799999,"preClose":1862.664,"halted":0,"volume":87221053,"delay":0,"changeRate":-0.020228,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Not Yet Opened","change":-37.678467,"latestTime":"10-01 16:00:00 EDT","open":1861.7568,"high":1862.6892,"low":1823.9656,"amount":8251423215.379974,"amplitude":0.020789,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1790928000000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":4.925071,"peRate":47.825349,"turnoverRate":0.006287,"increases":4,"decrements":15,"flats":0,"marketCap":1483952897195.5,"floatMarketCap":1448889043856},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4568\",,,,,undefined,":{"symbol":"BK4568","high":1862.6892,"amplitude":0.020789,"preClose":1862.664,"low":1823.9656,"pbRate":"4.925071","latestPrice":1824.9855,"volume":87221053,"delay":0,"open":1861.7568,"prevYearClose":1637.1339,"prevWeekClose":1903.4879,"prevMonthClose":1862.664,"prevQuarterClose":1862.664,"fiveDayClose":1892.1925,"twentyDayClose":1903.6779,"sixtyDayClose":1786.0701,"secType":"PLATE","market":"US","turnoverRate":0.006287,"peRate":47.825349,"marketCap":1483952897195.5,"floatMarketCap":1448889043856,"timestamp":1790884799999,"nameCN":"Anti-Pandemic Concept"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4568\",,,,undefined,":{"bkCode":"BK4568","up":4,"down":15,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4568\",pageSize:20,pageCount:6,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2670259374","title":"Pfizer's Tilrekimig Phase 3 Program Seen as Potential Upside Driver, UBS Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2670259374","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670259374?lang=en_us&edition=fundamental","pubTime":"2026-09-28 23:52","pubTimestamp":1790610732,"startTime":"0","endTime":"0","summary":"Pfizer's  new phase 3 studies of tilrekimig in atopic dermatitis and asthma may drive upside if results are positive, UBS Securities said Friday in a report.The adult atopic-dermatitis study will be run head-to-head against Dupixent, which is developed jointly by Sanofi  and Regeneron Pharmaceuticals , and UBS said the potential commercial contribution is not yet reflected in consensus estimates.Topline data released in March showed competitive placebo-adjusted EASI-75 rates of about 50% at the middle and high doses, and UBS said Pfizer is likely working to maximize efficacy at the middle-dose level.UBS maintained its neutral rating on Pfizer stock with a $27 price target.Price: 28.59, Change: -0.09, Percent Change: -0.30","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4007","LU0225771236.USD","BK4568","LU1894683264.USD","IE00B19Z3581.USD","BK4585","LU1883839398.USD","SG9999001176.SGD","SG9999002224.SGD","IE00B3T34201.USD","LU0321505439.SGD","BK4534","LU1023059063.AUD","LU1894683348.USD","LU0234572021.USD","LU0122379950.USD","IE00BBT3K403.USD","LU0170899867.USD","LU0456855351.SGD","BK4588","IE0002270589.USD","SG9999002232.USD","BK4592","LU0306806265.USD","BK4599","IE00BLSP4239.USD","SGXZ57979304.SGD","LU1066053197.SGD","LU0225284248.USD","IE00BLSP4452.SGD","LU0985481810.HKD","LU1066051498.USD","LU1057294990.SGD","SG9999003800.SGD","BK4550","LU0289739699.SGD","PFE","LU0306807586.USD","BK4533","LU0868494617.USD","LU0321505868.SGD","OZEM","IE00B19Z3B42.SGD","SG9999001176.USD","SG9999011175.SGD","BK4581","SG9999013999.USD","LU0058720904.USD","LU2596442595.SGD","IE000M9KFDE8.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670125563","title":"BioNTech to Proceed with Site Closures After Failing to Find Buyer","url":"https://stock-news.laohu8.com/highlight/detail?id=2670125563","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670125563?lang=en_us&edition=fundamental","pubTime":"2026-09-28 22:35","pubTimestamp":1790606100,"startTime":"0","endTime":"0","summary":"BioNTech said it would proceed with the closure of sites after it couldn't reach agreements to sell the facilities.\"Despite the intensive efforts of all parties involved and a broad-based sales process, it was unfortunately not possible to realize a sale,\" the company said Monday.In May, BioNTech said it would exit its Idar-Oberstein and Marburg sites in Germany, as well as its operations in Singapore and other facilities owned by CureVac before its acquisition, but that it would explore options for a partial or total sale for each. The company said at the time it expected the decision to affect up to 1,860 positions in total.The company said in August that a fund advised by Dubag Group would acquire its JPT Peptide Technologies subsidiary to ensure the business's continuity.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4548","BNTX","BK4139","BK4551","BK4588","BK4585","BK4535","BK4568"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670255552","title":"US Drugmakers Turn to China for Licensing Deals","url":"https://stock-news.laohu8.com/highlight/detail?id=2670255552","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670255552?lang=en_us&edition=fundamental","pubTime":"2026-09-28 22:31","pubTimestamp":1790605880,"startTime":"0","endTime":"0","summary":"FACTBOX-US drugmakers turn to China for licensing dealsSept 28 (Reuters)-MerckMRK.Non Monday agreed to payChinese biotechSciBrunch Therapeutics $400 million upfront for global rights to an experimenta","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260928:nL4N45K0UD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0203201768.USD","SG9999014914.USD","IE00BBT3K403.USD","LU0203202063.USD","SG9999018857.SGD","IE00B19Z3581.USD","TBXU","LU1244550494.USD","LU0868494617.USD","LU0882574139.USD","LU1069344957.HKD","LU2357627491.SGD","LU0965509010.AUD","BK4550","ELIS","LU2023250330.USD","IE00BLSP4452.SGD","LU0965509101.SGD","LU0417517546.SGD","LU1941712348.USD","SG9999015358.SGD","IE0002141913.USD","LU1868837136.USD","LU1116320901.HKD","LU0868494708.USD","LU2168564222.USD","LU0211327993.USD","IBB","SGXZ51526630.SGD","LU2242646821.SGD","BK4592","LU1934455277.USD","LU1670711040.USD","LU1201861249.SGD","SG9999018865.SGD","LU2417539215.USD","LU0320765646.SGD","LU0466842654.USD","SG9999015341.SGD","LU0985320562.USD","LU2097828474.EUR","LU0256863811.USD","LU1093756168.USD","LU1066051811.HKD","LU1839511570.USD","LU0203347892.USD","LU0943347566.SGD","LU1670711123.USD","SG9999014575.USD","LU0174119429.USD","LU2125154778.USD","IE00BFSS8Q28.SGD","LU0070302665.USD","LU2461242641.AUD","LU2347655073.USD","SGXZ57979304.SGD","LU1831875114.USD","LU0795875169.SGD","IE00B4R5TH58.HKD","LU0128525929.USD","LU2552382215.SGD","LU2361045086.USD","LU2433249047.HKD","IE00B2B36J28.USD","SG9999001176.SGD","LU1116320737.USD","IE00BWXC8680.SGD","LU1670710661.SGD","LU0069063385.USD","BK4534","IE0004445239.USD","LU2471134952.CNY","LU2471134879.HKD","IE0009355771.USD","AGNG","IE000WAW04H5.SGD","LU1917777945.USD","LU2097828557.USD","LLII","LU1929549753.HKD","LU2125154935.USD","LU0320765992.SGD","LU0820562030.AUD","LU2089984988.USD","LU0211328371.USD","LU0689626769.HKD","LU1023059063.AUD","LU2750360641.GBP","LU2168564495.EUR","IE000M9KFDE8.USD","LU0661504455.SGD","SG9999017495.SGD","IE00B3PB1722.GBP","LU0502904849.HKD","LU1035775433.USD","LU0985481810.HKD","HK0000165453.HKD","LU2237443978.SGD","LU0289961442.SGD","LU0787776722.HKD","LU2168564065.EUR","LU1551013425.SGD","MEDX","IE00B42XCP33.USD","LU1934455194.USD","LU2106854487.HKD","IE00BK4W5L77.USD","LU1571399168.USD","HRTS","LU0463099449.HKD","LU1267930730.SGD","LLYX","OZEM","LU1585245621.USD","LU1127390331.HKD","LU1064131342.USD","LU2168563687.JPY","LU1883839398.USD","LU2237443465.HKD","LU0980610538.SGD","LU0306806265.USD","IE00B1XK9C88.USD","LU0471298694.HKD","LU1066051498.USD","LU2462591350.SGD","PPH","SG9999003800.SGD","LU0130517989.USD","LU2242644610.SGD","SG9999013999.USD","LU1066053197.SGD","LU2112291526.USD","LU1814569148.SGD","PFE","LU1969619763.USD","LU2468319806.SGD","LU0345770308.USD","LU1670628061.USD","LU0689472784.USD","IE00B7KXQ091.USD","LU0162691827.USD","SG9999015986.USD","LU0203345920.USD","LU1732800096.USD","SG9999014559.SGD","LU0225283273.USD","LU0823434740.USD","LU2324357040.USD","LU0124676726.USD","ELIL","SGXZ31699556.SGD","LU0708995401.HKD","LU2242652126.USD","LU1496350502.SGD","LU0256863902.USD","LU0244354667.USD","LU0964807845.USD","LU0823434583.USD","LU1720051108.HKD","LU0058720904.USD","BK4533","SG9999014906.USD","LU0354030438.USD","LU1323610961.USD","SGXZ99366536.SGD","LU0057025933.USD","LU1988902786.USD","LU0198837287.USD","LU1868837300.USD","LU1366192091.USD","LU1069347547.HKD","IE00B1BXHZ80.USD","BK4599","LU2360106947.USD","LU0477156953.USD","LU2462157665.USD","LU2237443622.USD","LU2211815571.USD","LU1623119135.USD","BK4559","LU1188198961.HKD","LU0353189763.USD","LU0823416689.USD","LU1979441026.SGD","LU2456880835.USD","IE00BGHQF631.EUR","SG9999014898.SGD","SG9999001440.SGD","IE00B775H168.HKD","LU2129689431.USD","BK4566","GB00BDT5M118.USD","LU0006306889.USD","LU0225771236.USD","IE00BJJMRX11.SGD","IE00BLSP4239.USD","IE0001KFT4U8.USD","LU0323591593.USD","LU1003077747.HKD","LU0882574055.USD","LU0306807586.USD","LU0320765059.SGD","LU2357305700.SGD","LU0683600562.USD","SG9999015978.USD","LU1551013342.USD","XLV","IE00BJLML261.HKD","LU0170899867.USD","BK4516","LU0820561818.USD","IE00BKDWB100.SGD","LU0234572021.USD","SG9999014880.SGD","LU0353189680.USD","LU1057294990.SGD","LU2347655156.SGD","LU1983299246.USD","LU2360032135.SGD","LU2750360997.AUD","IE00B4JS1V06.HKD","LU1093756325.SGD","LU2097828714.EUR","RXL","LU0949170772.SGD","LU2552382058.USD","LU0234570918.USD","BK4581","LU1061106388.HKD","LU1989772840.SGD","LU1670627923.USD","LU0225284248.USD","LU2271345857.HKD","LU0237698245.USD","LU1232071149.USD","LU0708994859.HKD","LU2168564149.EUR","BMY","SG9999002224.SGD","LU1868836757.USD","LU2023250843.SGD","LU2756315664.SGD","LU1236620834.HKD","LU1712237335.SGD","LU0511384066.AUD","LU1162221912.USD","SG9999014542.SGD","ABBV","LU1496350171.SGD","LU0321505439.SGD","LU0345770993.USD","SGXZ81514606.USD","GDOC","LU1548497426.USD","LU0859254822.USD","IE000F7OJYX1.SGD","PAWZ","SG9999011175.SGD","LU2097828805.USD","LLYZ","LU1691799644.USD","LU2023250504.SGD","LU0672654240.SGD","CURE","SG9999015945.SGD","LU0267386448.USD","LU2089283258.USD","MRK","IE0005OL40V9.USD","LU2097828631.EUR","IE00BFXG1179.USD","LU1244550221.USD","LU2125909593.SGD","IE00BJJMRY28.SGD","LU2491050071.SGD","LU2488822045.USD","WDNA","LU1291159041.SGD","LU0472753341.HKD","LU1037948541.HKD","LU0726765562.USD","TRUH","LU0289739343.SGD","LU0210536198.USD","LU1430594728.SGD","BK1583","BK1589","LU0395794307.EUR","LU0122379950.USD","LU1989771016.USD","REGN","BMED","LU0326950275.SGD","SG9999014567.USD","SG9999015952.SGD","LU2089284900.SGD","MHIP","GLAM","LU0096364046.USD","LU0965508806.USD","LU0942090050.USD","LU1035773651.USD","LU0289739699.SGD","LU0316494557.USD","LU1699723380.USD","BK4139","LU2896262040.SGD","MEDI","LU0097036916.USD","LU1934455863.HKD","IE0000B7K699.USD","LU0456855351.SGD","LU0310800379.SGD","LU2087621335.USD","LU1261432733.SGD","LU2129689605.HKD","LU2237443895.HKD","LU1037948897.HKD","LU2087625088.SGD","01801","IHE","LU1267930573.SGD","LU2471134796.USD","LU0889565916.HKD","LU0321505868.SGD","LU0149534421.HKD","ILDR","THNR","SG9999001176.USD","LU2756315318.SGD","LU0211331839.USD","LLY","LU0053666078.USD","IYH","LU2237443382.USD","LU2471134523.USD","LU1720051017.SGD","LU2361044949.HKD","LU0208291251.USD","LU2133065610.SGD","IE0002270589.USD","IE00BJJMRZ35.SGD","LU2213496289.HKD","LU2125909247.SGD","IE000BZT7R73.USD","LU0455707207.USD","IE000SO60NU8.SGD","LU0553294199.USD","LU0130102774.USD","LU0861579265.USD","LU0238689110.USD","LU1894683348.USD","IBBQ","LU2108987350.USD","LU0385154629.USD","IE00BN29S564.USD","IE00BVYPNW00.USD","LU2063271972.USD","LU0354030511.USD","LU0640476718.USD","LU0061475181.USD","IE00B19Z3B42.SGD","LU2265009873.SGD","LU2129689514.USD","LU2596442595.SGD","LU2328871848.SGD","LU1923622614.USD","IE00BFTCPJ56.SGD","LU0072461881.USD","LU2237438978.USD","LU0265550359.USD","LU0786609619.USD","LU1244550577.SGD","LU2552382132.HKD","FTXH","CANC","IE0004445015.USD","IE00BJT1NW94.SGD","IE00BSNM7G36.USD","LU2491050154.USD","VHT","BK4532","LU0265550946.USD","SG9999002232.USD","LU1941712264.USD","BK4568","LU2111349929.HKD","IE00BFSS7M15.SGD","LU1718418525.SGD","LU1894683264.USD","IXJ","LU2602419157.SGD","LU1280957306.USD","LU0607220059.USD","LU1670710588.SGD","LU2746668461.USD","KURE","LU0648001328.SGD","LU0545039389.USD","LU2023251221.USD","LU2362541513.USD","LU0432979614.USD","IE000MB6IJN5.SGD","IE00BN8TJ469.HKD","LU0310799852.SGD","LU2362541273.HKD","BK4588","LU2028103732.USD","LU0158827948.USD","LU0094547139.USD","LU0471298777.SGD","LU0109394709.USD","LU0098860793.USD","LU2361044865.SGD","LU0965509283.SGD","LU0133085943.USD","FHLC","LU0114720955.EUR","TMED","LU1267930490.SGD","LU1032466523.USD","LU1074936037.SGD","PJP","IE00BKPKM429.USD","LU0320765489.SGD","LU0029864427.USD","LU0738911758.USD","LU0266013472.USD","LU1236620750.USD","LU1989772923.USD","LU2237443549.SGD","BK4007","LU0079474960.USD","LU1974910355.USD","LU0795875086.SGD","LU2491049909.HKD","LU1868836591.USD","LU2264538146.SGD","IE00BDGV0183.EUR","IE00BK4W5M84.HKD","LU0106261372.USD","LU0109391861.USD","BK4585","BK1161","LU0158827781.USD","LU1629891620.HKD","LU1732799900.SGD","IE00BVYPNV92.GBP","LU2746668974.SGD","LU0912757837.SGD","LU2362540622.SGD","LU2236285917.USD","LU1804176565.USD","JDOC","LU0820561909.HKD","LU1145028129.USD","LU1066051225.USD","IE00B3T34201.USD","BBH","LU1868836914.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670237478","title":"NanoViricides Starts Phase II DRC Trial of Oral NV-387 Gummies in Bundibugyo Ebola Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2670237478","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670237478?lang=en_us&edition=fundamental","pubTime":"2026-09-28 20:45","pubTimestamp":1790599532,"startTime":"0","endTime":"0","summary":"NanoViricides starts Phase II DRC trial of oral NV-387 gummies in Bundibugyo Ebola patientsNanoViricides began enrolling and dosing patients in a Phase II trial of NV-387 oral gummies for Ebola in the","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260928:nNDL2v5BJN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NNVC","BK4139","BK4568"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670423256","title":"Humacyte Adds Scott Coward to Board, Names Him to Audit Committee","url":"https://stock-news.laohu8.com/highlight/detail?id=2670423256","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670423256?lang=en_us&edition=fundamental","pubTime":"2026-09-28 20:03","pubTimestamp":1790596983,"startTime":"0","endTime":"0","summary":"Humacyte adds Scott Coward to board, names him to audit committeeHumacyte added Scott Coward and Paul Kuznik to its board as it expands the Symvess launch and prepares an ATEV dialysis-access launch.C","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260928:nNDL2fwfyJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IHI","LU1721429741.USD","LU0122379950.USD","LU0211331839.USD","LU2133065610.SGD","LU0320765489.SGD","LU2237957902.USD","HUMA","TMED","BK4568","LU2468319806.SGD","LU1023059063.AUD","LU0266013472.USD","IE00BN0W2V16.EUR","LU0208291251.USD","ABT","IE00BQXX3C00.GBP","SG9999014021.USD","IE00BN0W2W23.USD","LU1057294990.SGD","BK4566","PJP","IE0009355771.USD","LU2095319765.USD","NDAQ","SG9999002224.SGD","LU1989763690.USD","LU0314104364.USD","BK4112","IE00B2B36J28.USD","BK4585","LU0170899867.USD","LU1983299246.USD","IE00BKPKM429.USD","SG9999002232.USD","BCDF","LU2210150020.SGD","SG9999004303.SGD","IE00B3QW5Z07.USD","SGXZ41872573.SGD","IE0002141913.USD","LU2237957811.SGD","LU1670628061.USD","IE00B64PRP62.GBP","SG9999014005.SGD","LU0070302665.USD","BK4588","LU0058720904.USD","BK4082","IE00BQXX3F31.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670019231","title":"Xilio Therapeutics Names Yariv Houvras Chief Medical Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2670019231","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670019231?lang=en_us&edition=fundamental","pubTime":"2026-09-28 19:30","pubTimestamp":1790595055,"startTime":"0","endTime":"0","summary":"Xilio Therapeutics names Yariv Houvras chief medical officerXilio Therapeutics named Yariv J. Houvras chief medical officer on Sept. 28, 2026.He previously led clinical and translational development a","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260928:nNDL8GCH5H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BMED","LU0861579265.USD","LU1934455863.HKD","LU2112291526.USD","IE00B19Z3581.USD","IE00BQXX3C00.GBP","BCDF","LU0965509283.SGD","LU1934455277.USD","LU1839511570.USD","BIB","LU0823416689.USD","SG9999015952.SGD","LU1061106388.HKD","LU2210149790.SGD","SG9999014021.USD","LU2089984988.USD","TBXU","IE00BKPKM429.USD","BK4566","LU1430594728.SGD","BK4568","BK4583","LU1571399168.USD","IE00B19Z3B42.SGD","TMED","LU1066051498.USD","IBB","LU1037948897.HKD","LU2468319806.SGD","IE00B3QW5Z07.USD","BBH","MEDI","IE00BN0W2W23.USD","LU2087621335.USD","NDAQ","IE00BN0W2V16.EUR","IE00BKVL7J92.USD","GILD","LU0859254822.USD","LU2210150020.SGD","LU1066053197.SGD","SG9999014013.SGD","IE00B3T34201.USD","LU0965509101.SGD","XLO","BK4532","IBBQ","SG9999015978.USD","LU0234570918.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670239638","title":"Pfizer to Present Phase 3 SigVie-002 Survival Data for Sigvotatug Vedotin in Previously Treated NSCLC at ESMO 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2670239638","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670239638?lang=en_us&edition=fundamental","pubTime":"2026-09-28 18:45","pubTimestamp":1790592352,"startTime":"0","endTime":"0","summary":"Pfizer to present Phase 3 SigVie-002 survival data for sigvotatug vedotin in previously treated NSCLC at ESMO 2026Pfizer flagged 45 oncology abstracts for ESMO 2026 in Madrid, with several readouts sc","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260928:nNDLb6xnBP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999003800.SGD","OZEM","LU0306807586.USD","BK4007","IE00B3T34201.USD","LU1057294990.SGD","LU1894683348.USD","IE000M9KFDE8.USD","BK4592","LU0122379950.USD","LU0306806265.USD","IE00BLSP4239.USD","BK4550","BK4534","LU1883839398.USD","LU0170899867.USD","LU0868494617.USD","LU1023059063.AUD","SG9999001176.SGD","LU0225284248.USD","BK4588","BK4581","LU0321505868.SGD","LU1066051498.USD","PFE","IE00BLSP4452.SGD","IE00B19Z3B42.SGD","LU0058720904.USD","SG9999013999.USD","BK4568","LU0985481810.HKD","LU1894683264.USD","SG9999002232.USD","IE0002270589.USD","BK4533","LU2596442595.SGD","LU0321505439.SGD","LU0456855351.SGD","IE00BBT3K403.USD","SG9999002224.SGD","SG9999011175.SGD","SG9999001176.USD","LU0234572021.USD","BK4599","LU0289739699.SGD","LU1066053197.SGD","IE00B19Z3581.USD","BK4585","LU0225771236.USD","SGXZ57979304.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670235143","title":"Berenberg Bank Sticks to Its Hold Rating for Bilfinger (0NRG)","url":"https://stock-news.laohu8.com/highlight/detail?id=2670235143","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670235143?lang=en_us&edition=fundamental","pubTime":"2026-09-28 17:55","pubTimestamp":1790589346,"startTime":"0","endTime":"0","summary":"In a report released today, Andreas Wolf from Berenberg Bank maintained a Hold rating on Bilfinger, with a price target of €63.00. According to Tip...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/berenberg-bank-sticks-to-its-hold-rating-for-bilfinger-0nrg-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/berenberg-bank-sticks-to-its-hold-rating-for-bilfinger-0nrg-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4551","BK4548","BK4585","BK4139","BK4535","BK4588","BK4568","BNTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670043824","title":"Abbott Study Links CGM Use in Type 2 Diabetes Patients on Basal Insulin to 45% Lower 12-Month Mortality Risk","url":"https://stock-news.laohu8.com/highlight/detail?id=2670043824","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670043824?lang=en_us&edition=fundamental","pubTime":"2026-09-28 06:05","pubTimestamp":1790546750,"startTime":"0","endTime":"0","summary":"Abbott study links CGM use in Type 2 diabetes patients on basal insulin to 45% lower 12-month mortality riskAbbott flagged new real-world data linking continuous glucose monitoring use to fewer deaths","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260927:nNDL4zn4gq:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4533","BK4082","IE00BFTCPJ56.SGD","LU0122379950.USD","LU0170899867.USD","LU0882574055.USD","LU1989763427.SGD","LU2112291526.USD","BK4566","LU0289739699.SGD","LU0266013472.USD","TMED","LU2237957811.SGD","LU2468319806.SGD","LU2237957902.USD","LU2089984988.USD","LU0868494617.USD","LU0432979614.USD","LU1691799644.USD","LU1989763690.USD","IE00BJJMRZ35.SGD","IE00B2B36J28.USD","LU0234572021.USD","LU1057294990.SGD","LU1670628061.USD","LU0208291251.USD","BK4585","IE0002141913.USD","LU1061106388.HKD","IE00B4R5TH58.HKD","IE0009355771.USD","LU1670627923.USD","LU2211815571.USD","LU2324357040.USD","LU0058720904.USD","SG9999002224.SGD","ABT","IE00BJT1NW94.SGD","BK4504","BK4588","IHI","BK4568","SGXZ41872573.SGD","SG9999004303.SGD","BK4581","SGXZ23171101.USD","LU1914381329.SGD","SG9999002232.USD","LU1721429402.USD","PJP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670474940","title":"Pfizer (PFE) Bets Big on RSV and Cancer Care","url":"https://stock-news.laohu8.com/highlight/detail?id=2670474940","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670474940?lang=en_us&edition=fundamental","pubTime":"2026-09-26 23:02","pubTimestamp":1790434935,"startTime":"0","endTime":"0","summary":"Pfizer ( ($PFE) ) has been popular among investors this week. Here is a recap of the key news on this stock. Pfizer Inc. is quietly building new pi...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/weekend-updates/pfizer-pfe-bets-big-on-rsv-and-cancer-care?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/weekend-updates/pfizer-pfe-bets-big-on-rsv-and-cancer-care?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1023059063.AUD","LU1066053197.SGD","IE00BBT3K403.USD","BK4581","LU0058720904.USD","BK4550","LU1066051498.USD","LU0234572021.USD","LU0225771236.USD","IE0002270589.USD","LU0321505439.SGD","LU0306806265.USD","LU0289739699.SGD","LU0321505868.SGD","SG9999001176.USD","SGXZ57979304.SGD","BK4568","LU1894683264.USD","LU2596442595.SGD","LU1057294990.SGD","BK4592","BK4534","IE00B19Z3581.USD","LU0306807586.USD","SG9999002224.SGD","IE00B3T34201.USD","LU1883839398.USD","OZEM","IE00B19Z3B42.SGD","SG9999011175.SGD","LU0868494617.USD","LU0456855351.SGD","LU0985481810.HKD","PFE","IE00BLSP4239.USD","SG9999013999.USD","BK4588","IE000M9KFDE8.USD","LU1894683348.USD","BK4599","SG9999003800.SGD","LU0170899867.USD","BK4585","IE00BLSP4452.SGD","LU0225284248.USD","BK4533","BK4007","SG9999001176.SGD","SG9999002232.USD","LU0122379950.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670222014","title":"NYSE Most Active Issues","url":"https://stock-news.laohu8.com/highlight/detail?id=2670222014","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670222014?lang=en_us&edition=fundamental","pubTime":"2026-09-26 05:40","pubTimestamp":1790372400,"startTime":"0","endTime":"0","summary":"Nu Holdings Cl A              NU    52,825,762     13.59     0.03      0.22. Nike Cl B                    NKE    38,110,169     35.75    -0.24     -0.67. BitMine Immersion Techs     BMNR    31,474,128     27.56    -0.47     -1.68. Bank of America              BAC    28,362,710     56.70     0.67      1.20","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FTXO","LU0980610538.SGD","KBWB","APIE","IE000M9KFDE8.USD","LU1496350502.SGD","IYG","LU0211331839.USD","LU0106831901.USD","SAPH","LU1894683264.USD","SG9999002232.USD","LU1880398554.USD","LU1861558580.USD","SG9999002224.SGD","XLF","LU0058720904.USD","LU1791807156.HKD","FNCL","AADR","PATX","TFNS","BK4568","LU0203347892.USD","LU0306806265.USD","OZEM","SG9999001176.USD","CVY","IYF","LU1074936037.SGD","IE00BBT3K403.USD","LU2133065610.SGD","ARMH","DINT","DIVL","UYG","BK4547","BK4533","LU0289739699.SGD","LU0320765646.SGD","LU0321505868.SGD","BAC","LU1035773651.USD","VFH","BBUL","PATH","LU0208291251.USD","PFE","BK4559"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670706429","title":"NASDAQ New 52-Week Highs and Lows","url":"https://stock-news.laohu8.com/highlight/detail?id=2670706429","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670706429?lang=en_us&edition=fundamental","pubTime":"2026-09-26 02:22","pubTimestamp":1790360520,"startTime":"0","endTime":"0","summary":"ARC Group Secs Acqn I        FJDIU       10.14         26,835. Gl X Genomics & Biotech      GNOM        70.83         11,765. GrShr 2x Long AMD Daily      AMDL        86.43      1,432,877. Invsc BS 2036 Mun Bd         BSMA        27.15          6,786. Leverage 2X Lg AMD Dly       AMDG       145.58         21,664","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0274383776.USD","BK4139","LU1989764748.USD","ILDR","QID","QMAR","BK4534","LU1852331112.SGD","NJAN","LU2456880835.USD","WISE","GNOM","TQQQ","LU2462591350.SGD","SQQQ","IE00BMPRXR70.SGD","SGXZ51526630.SGD","BK4512","BK4614","LU0174119429.USD","LU2360107168.USD","AMDG","LU0082616367.USD","LU2361044949.HKD","IE00BKPKM429.USD","IE00B64PRP62.GBP","LU0390134368.USD","TQQY","TEK","BK4533","LU1989772923.USD","BK4112","IE00B3QW5Z07.USD","LU0314104364.USD","GPIQ","LU2098885051.SGD","IE00BMPRXQ63.HKD","SAMD0main","LU2247934214.USD","AMDD","LU0642271901.SGD","03086","LU1804176565.USD","LU2054465674.USD","PSQ","QDEC","QQQX","FAI","IETC","LU1989764664.SGD","BK4529","IE00B1BXHZ80.USD","LU2355687059.USD","XNTK","SG9999014039.USD","BK4588","LU0719512351.SGD","LU1861215975.USD","IE00BN0W2W23.USD","QQQA","SMH","AMYY","LU0109391861.USD","LU2290526834.HKD","SG9999014021.USD","WDNA","LU0109392836.USD","03034","LU1880398471.USD","LU1064131342.USD","AMDY","LU2458330243.SGD","IDNA","LU0672654240.SGD","BK4605","LU0210536198.USD","LU0889565833.HKD","LU1267930730.SGD","LU2360106780.USD","LU2860962120.EUR","LU2242649171.HKD","SOXX","USXF","AMUU","IE00B5949003.HKD","IE00BMPRXN33.USD","AIQ","LU0348723411.USD","IE00BQXX3F31.USD","BK4612","LU0251132253.USD","LU2210150020.SGD","LU0198837287.USD","BK4585","SG9999001424.SGD","LU1861559042.SGD","BK4573","SG9999014013.SGD","AMDL","IE00BN0W2V16.EUR","BK4532","LU0823434740.USD","LU0823434583.USD","LU2458330169.SGD","SGXZ99366536.SGD","SMHX","IE00BN0W2T93.GBP","LU0320765059.SGD","LU1242518857.USD","LU2361045086.USD","SGXZ81514606.USD","07261","LU1951198990.SGD","QLD","BAI","QQQM","BK4566","IE0009356076.USD","LU1861558580.USD","BK4501","IE00BGHQF748.EUR","LGHT","CHPS","CNAV",".IXIC","SOXY","BK4543","LEGR","LU2108987350.USD","07568","NDAQ","IE00BQXX3C00.GBP","IE00BQXX3D17.EUR","LU0792757196.USD","BK4554","IE00BZ1G4Q59.USD","LU2361044865.SGD","LU0048584097.USD","BCDF","NDX","LU2461242641.AUD","BK4568","LU1880398554.USD","LU0823421333.USD","LU0056508442.USD","LU1242518931.SGD","GAMR",".HXC","LU1316542783.SGD","09834","LU2931357623.SGD","03455","LU2250418816.HKD","07522","BK4141","LU0889566641.SGD","TRFK","LU1861220033.SGD","PSI","LU1988902786.USD","LU2210149790.SGD","LU2095319765.USD","AMDS","AIS","QQQ","DAMD","BK4575","AMDW","LU0786609619.USD","BK4548","BK4551","IE0004445239.USD","SG9999014005.SGD","NJUL","02834","09086","LU1923623000.USD","MRNA","LU2417539215.USD","IE00BKVL7J92.USD","LU0133085943.USD","LU2265009873.SGD","MRNY","LU1951200564.SGD","AMDU","TTEQ","LU2089985449.USD","LU2896262040.SGD","AMDC","LU2236285917.USD","07266","LU1267930813.SGD","NAPR","LU0081259029.USD","AMD","LU2543165471.USD","LU1303367103.USD","LU1989772840.SGD","FTXL","MRNX","LU0979878070.USD","WUGI","LU1232071149.USD","LU0823421416.USD","LU0127658192.USD","NOCT","LU0708995401.HKD","LU2264538146.SGD","IE0001KFT4U8.USD","LU1803068979.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670426456","title":"Pfizer Targets Cancer-Related Weight Loss With New Ponsegromab Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2670426456","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670426456?lang=en_us&edition=fundamental","pubTime":"2026-09-26 00:31","pubTimestamp":1790353868,"startTime":"0","endTime":"0","summary":"Pfizer Inc ($PFE) announced an update on their ongoing clinical study. Pfizer Inc. (PFE) is launching a new study to test ponsegromab in adults wit...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/pfizer-targets-cancer-related-weight-loss-with-new-ponsegromab-study?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/pfizer-targets-cancer-related-weight-loss-with-new-ponsegromab-study?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0058720904.USD","BK4592","SG9999003800.SGD","IE0002270589.USD","SG9999001176.USD","LU1883839398.USD","LU0225771236.USD","IE000M9KFDE8.USD","LU0234572021.USD","IE00BLSP4239.USD","BK4581","LU0225284248.USD","LU0321505439.SGD","PFE","LU1023059063.AUD","SG9999001176.SGD","BK4533","SG9999011175.SGD","LU0868494617.USD","BK4007","BK4550","LU0122379950.USD","LU1066051498.USD","SGXZ57979304.SGD","BK4534","BK4599","BK4568","IE00B19Z3581.USD","LU0289739699.SGD","SG9999002232.USD","BK4588","LU1894683264.USD","LU0306806265.USD","LU1066053197.SGD","LU2596442595.SGD","LU0321505868.SGD","LU0456855351.SGD","LU0985481810.HKD","LU0170899867.USD","IE00BBT3K403.USD","BK4585","IE00B3T34201.USD","LU1057294990.SGD","IE00B19Z3B42.SGD","LU1894683348.USD","SG9999013999.USD","OZEM","LU0306807586.USD","SG9999002224.SGD","IE00BLSP4452.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670426474","title":"Pfizer’s RSV Revaccination Trial Targets Durable Booster Revenue in High‑Risk Adults","url":"https://stock-news.laohu8.com/highlight/detail?id=2670426474","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670426474?lang=en_us&edition=fundamental","pubTime":"2026-09-26 00:30","pubTimestamp":1790353857,"startTime":"0","endTime":"0","summary":"Pfizer Inc ($PFE) announced an update on their ongoing clinical study. Pfizer Inc. (PFE) is running a phase 3 study called “A Study to Learn About ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/pfizers-rsv-revaccination-trial-targets-durable-booster-revenue-in-highrisk-adults?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/pfizers-rsv-revaccination-trial-targets-durable-booster-revenue-in-highrisk-adults?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1057294990.SGD","LU1883839398.USD","SGXZ57979304.SGD","SG9999011175.SGD","IE00B19Z3581.USD","LU0456855351.SGD","SG9999013999.USD","LU0122379950.USD","BK4599","LU1894683264.USD","BK4585","LU1066051498.USD","LU0321505868.SGD","LU2596442595.SGD","BK4588","BK4007","LU0321505439.SGD","BK4533","IE00B3T34201.USD","BK4581","IE00BLSP4452.SGD","LU0234572021.USD","BK4592","SG9999001176.SGD","SG9999003800.SGD","LU0868494617.USD","LU0306807586.USD","LU0225771236.USD","LU0306806265.USD","LU0985481810.HKD","BK4568","PFE","BK4534","OZEM","SG9999002232.USD","IE00BLSP4239.USD","LU0170899867.USD","LU1894683348.USD","LU1066053197.SGD","SG9999002224.SGD","BK4550","IE00B19Z3B42.SGD","LU0289739699.SGD","IE00BBT3K403.USD","LU0225284248.USD","LU1023059063.AUD","IE0002270589.USD","SG9999001176.USD","LU0058720904.USD","IE000M9KFDE8.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670242653","title":"AstraZeneca Advances Friday, Outperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2670242653","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670242653?lang=en_us&edition=fundamental","pubTime":"2026-09-26 00:09","pubTimestamp":1790352540,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.AstraZeneca PLC  shares rallied 1.23% to GBP125.52 Friday, on what proved to be an all-around positive ","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2237443622.USD","LU2237443382.USD","LU0889565916.HKD","LU2237443895.HKD","LU0432979614.USD","AZNH","LU0320765992.SGD","LU2456880835.USD","LU1829250122.USD","LU0310800379.SGD","LU2468319806.SGD","BK4568","LU2462157665.USD","LU0289739699.SGD","LU2237443465.HKD","BK4585","LU1267930573.SGD","LU0058720904.USD","BK4588","AZN","LU0109394709.USD","IE00B3T34201.USD","BK4007","LU0708994859.HKD","LU0128525929.USD","LU2089984988.USD","LU2237443549.SGD","LU0029864427.USD","LU2417539215.USD","LU2236285917.USD","LU2237443978.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670425143","title":"Innovation is Driving a New Bull Market in Biotech. 16 Ways to Play It, from Our Roundtable Experts.","url":"https://stock-news.laohu8.com/highlight/detail?id=2670425143","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670425143?lang=en_us&edition=fundamental","pubTime":"2026-09-25 23:39","pubTimestamp":1790350740,"startTime":"0","endTime":"0","summary":"A tidal wave of innovation in biotechnology is improving patient outcomes, transforming the industry's prospects, and lifting long-suffering biotech shares. Spurred by therapeutic breakthroughs and ne","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B1BXHZ80.USD","LU1069347547.HKD","LU0098860793.USD","LU0234572021.USD","LU2468319806.SGD","LU2112291526.USD","LU0965509101.SGD","LU2357627491.SGD","LU0965509283.SGD","LU0211331839.USD","IE00BJT1NW94.SGD","LU0289961442.SGD","PAWZ","LU0130517989.USD","IE0009355771.USD","LU1116320737.USD","IBB","LU1037948541.HKD","LU0320765489.SGD","LU0124676726.USD","IE00BSNM7G36.USD","LU0203345920.USD","LU0472753341.HKD","LU1037948897.HKD","LU0477156953.USD","LU0511384066.AUD","LU1116320901.HKD","LU1066051498.USD","SG9999015341.SGD","MRNX","LU0006306889.USD","LU0072461881.USD","JDOC","LU0965509010.AUD","LU1162221912.USD","LU1974910355.USD","BK4532","IE00BBT3K403.USD","SG9999002224.SGD","LU1093756325.SGD","LU0265550359.USD","SG9999001440.SGD","LU0868494708.USD","LU0648001328.SGD","LU2491049909.HKD","LU1983299246.USD","MRK","IE000M9KFDE8.USD","LU1585245621.USD","RXL","LU1035773651.USD","LU1430594728.SGD","LU1571399168.USD","LU1699723380.USD","LU2433249047.HKD","LU0289739343.SGD","LU1989771016.USD","LU1989772923.USD","LU0823416689.USD","IE00B2B36J28.USD","BK4568","IE00B4R5TH58.HKD","LU2361045086.USD","SG9999014559.SGD","IYH","SGXZ57979304.SGD","LU2106854487.HKD","MRNA","LU2023250504.SGD","XBI","LU0122379950.USD","LU0861579265.USD","BK4534","BMED","LU0106261372.USD","LU0289739699.SGD","WDNA","IHE","LU0069063385.USD","LU1066051225.USD","XLV","SG9999001176.SGD","TRUH","HRTS","IDNA","LU1934455194.USD","VHT","IE00BLSP4452.SGD","BK4550","LU1291159041.SGD","IE00BLSP4239.USD","LU1023059063.AUD","BK4585","BK4139","LU2360032135.SGD","LU1923622614.USD","SG9999014542.SGD","LU1057294990.SGD","PPH","LU1093756168.USD","IE0002141913.USD","LU0203347892.USD","LU2491050154.USD","LU2361044949.HKD","LU1061106388.HKD","LU0057025933.USD","LU1941712348.USD","BK4533","LU1934455277.USD","BK4548","LGHT","LU0432979614.USD","LU0965508806.USD","LU1066053197.SGD","IE00BJJMRZ35.SGD","LU1032466523.USD","LU0868494617.USD","SG9999013999.USD","LU0238689110.USD","LU0058720904.USD","LU0942090050.USD","BK4501","LU0130102774.USD","MRNY","LU0208291251.USD","GDOC","IE00BFTCPJ56.SGD","LU1934455863.HKD","LU1917777945.USD","SG9999001176.USD","LU1989772840.SGD","LU0266013472.USD","BK4516","LU2125909593.SGD","FTXH","LU2361044865.SGD","GNOM","LU0689626769.HKD","SG9999015358.SGD","LU2125154935.USD","LU0985320562.USD","IXJ","LU0162691827.USD","LU2125154778.USD","BK4007","LU0320765646.SGD","LU1941712264.USD","LU0265550946.USD","LU2023250843.SGD","SG9999014567.USD","BK4559","SG9999014575.USD","LU1201861249.SGD","LU2491050071.SGD","BK4581","SG9999002232.USD","BK4551","LU0070302665.USD","BK4588","LU0980610538.SGD","LU2089984988.USD","LU2461242641.AUD","IE00BN8TJ469.HKD","LU2324357040.USD","LU0859254822.USD","LU1929549753.HKD","LU2125909247.SGD","LU1066051811.HKD","FHLC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670142531","title":"European Equities Traded in the US as American Depositary Receipts Edge Higher in Friday Trading; Down for Week","url":"https://stock-news.laohu8.com/highlight/detail?id=2670142531","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670142531?lang=en_us&edition=fundamental","pubTime":"2026-09-25 23:15","pubTimestamp":1790349322,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were tracking modestly higher late Friday morning, increasing 0.31% to 1,915.69 on the S&P Europe Select ADR Index, which is down 1.1% for the week.From continental Europe, the gainers were led by semiconductor company Sequans Communications  and medical device maker EDAP TMS , which rose 4% and 2.2% respectively. They were followed by biotech firm Evaxion  and biopharmaceutical company Grifols , which increased 2.3% and 2.2% respectively.The decliners from continental Europe were led by accommodations booking site trivago  and petroleum refiner Equinor , which dropped 1.4% and 1.3% respectively. They were followed by biotech firm BioNTech  and internet browser company Opera , which lost 0.5% and 0.1% respectively.The gainers from the UK were led by software firm Endava  and communications company WPP , which advanced 9.1% and 2.7% respectively. They were followed by lenders Lloyds Banking Group  and Barclays , which in","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4077","BK4117","BK4535","AKTX","AMRN","NCNA","BK4009","BK4023","WPP.AU","BK4207","BK4201","BK4139","FOCL","DAVA.AU","TRVG","LU0648005311.SGD","LU0084288595.USD","BK4082","IEUR","LFGY","BK4007","DAVA","BCYC","BK4568","WPP","EPV","BK4588","BNTX","BK4107","BK4551","SQNS","BK4134","LYG","EVAX","BK4585","EQNR","AFG","BK4141","BK4548","GRFS","OPRA","BCS","BK4521"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670447855","title":"Ocugen Shares Rise on Provisional Approval for Retinitis Pigmentosa Treatment in Bahamas","url":"https://stock-news.laohu8.com/highlight/detail?id=2670447855","media":"Dow Jones","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670447855?lang=en_us&edition=fundamental","pubTime":"2026-09-25 19:49","pubTimestamp":1790336940,"startTime":"0","endTime":"0","summary":"Shares of Ocugen ticked higher after its treatment for retinitis pigmentosa, or RP, a type of genetic eye disorder, got provisional approval and priority designation from regulators in the Bahamas.The stock was up 2.9% to $1.03 in premarket trading on Friday. At Thursday's market close, shares were down 26% year to date.Ocugen said it got the approval for OCU400 from the Larta Board, the regulatory agency responsible for reviewing and approving longevity and regenerative therapy programs in the Bahamas.The biotechnology company plans to treat the first RP patient with OCU400 within 90 days following full Larta approval.OCU400 is currently in Phase 3 development, targeting a broad RP indication from early- to late-stage disease and pediatric to adult patients.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Ocugen Shares Rise on Provisional Approval for Retinitis Pigmentosa Treatment in Bahamas","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4568","BK4139","OCGN","BK4563"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670427334","title":"Johnson & Johnson says Tremfya met endpoints in Phase 4 STAR study","url":"https://stock-news.laohu8.com/highlight/detail?id=2670427334","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670427334?lang=en_us&edition=fundamental","pubTime":"2026-09-25 19:35","pubTimestamp":1790336153,"startTime":"0","endTime":"0","summary":"Johnson & Johnson announced that Tremfya met the primary and major secondary endpoints demonstrating both improvement in axial symptoms and reducti...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/johnson-johnson-says-tremfya-met-endpoints-in-phase-4-star-study-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/johnson-johnson-says-tremfya-met-endpoints-in-phase-4-star-study-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0203347892.USD","LU0234570918.USD","LU1551013342.USD","GDOC","LU0820561909.HKD","TRUH","LU0098860793.USD","IE00BFTCPJ56.SGD","LU1196500208.SGD","LU1496350502.SGD","RXL","VHT","FTXH","BMED","LU1280957306.USD","IYH","LU1145028129.USD","IE000M9KFDE8.USD","LU1674673428.USD","IHE","JNJ","LU0738911758.USD","LU1732799900.SGD","LU1261432733.SGD","IXJ","LU1057294990.SGD","LU1003077747.HKD","LU1066053197.SGD","MEDX","LU0889566641.SGD","LU0289961442.SGD","SGXZ57979304.SGD","PJP","IE00BZ1G4Q59.USD","BK4568","LU1032955483.USD","LU1066051498.USD","LU1221951129.SGD","LU1228905037.USD","IE00BKVL7J92.USD","LU1894683264.USD","LU0661504455.SGD","LU1244550494.USD","BK4559","SG9999002224.SGD","FHLC","XLV","JDOC","LU0820562030.AUD","IE00BLSP4239.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670421704","title":"Johnson & Johnson Announces Tremfya® (Guselkumab) is the First and Only Il-23 Inhibitor to Show Significant Improvement in Spinal Pain and Stiffness in Landmark Axial Psoriatic Arthritis (Psa) Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2670421704","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670421704?lang=en_us&edition=fundamental","pubTime":"2026-09-25 19:30","pubTimestamp":1790335800,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260925:nTUA659LC0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1066053197.SGD","VHT","LU2403377893.USD","BK4532","LU0949170772.SGD","XLV","IE00BBT3K403.USD","PJP","JNJ","FHLC","IE0001KFT4U8.USD","LU2896262040.SGD","SGXZ57979304.SGD","BK4568","LU0320765646.SGD","SGXZ80539844.SGD","LU0162691827.USD","GDOC","LU2236285917.USD","MEDX","LU0289961442.SGD","LU1196500208.SGD","LU2756315318.SGD","IE00B19Z3B42.SGD","IE000MB6IJN5.SGD","IE00BJJMRZ35.SGD","LU0098860793.USD","IHE","LU1244550577.SGD","LU0661504455.SGD","JDOC","BK4588","IE000M9KFDE8.USD","LU0820561818.USD","LU0345770993.USD","LU1914381329.SGD","LU1066051225.USD","IXJ","RXL","TRUH","LU1032466523.USD","IYH","BMED","LU1551013342.USD","LU2089984988.USD","BK4007","LU1929549753.HKD","FTXH","LU0122379950.USD","BK4559"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":11,"pageCount":6,"totalSize":216,"code":"91000000","status":"200"}]}}